/AVO.L
AVO.L Stock - Advanced Oncotherapy plc
Healthcare|Medical - DevicesLSE
$1.75-9.09%
$0.17 (-9.09%) • Aug 30
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.93
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AVO.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.73 – $1.77
TARGET (TP)$2.01
STOP LOSS$1.61
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.06
52W High$25.75
52W Low$1.75
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-2,339,255 | $-2,331,813 | $-2,025,494 | $-1,908,925 | $-365,470 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-23,736,754 | $-20,269,788 | $-20,659,460 | $-21,799,671 | $-14,492,595 |
| Net Income | $-35,248,716 | $-30,332,453 | $-20,794,606 | $-21,106,949 | $-13,660,371 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.09 | $-0.10 | $-0.10 | $-0.14 | $-0.18 |
Company Overview
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AVO.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.03
Q4 2022
EPS Surprise History
Q2 19
No data
Q4 19
No data
Q2 20
No data
Q4 20
No data
Q2 21
No data
Q4 21
No data
Q3 22
No data
Q4 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Nov 16, 2024 | — | — | — | — |
Q1 2024 | Feb 13, 2024 | — | — | — | — |
Q4 2023 | Nov 30, 2023 | — | — | — | — |
Q4 2022 | Dec 30, 2022 | — | $0.03 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.06 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.00 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.00 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-0.00 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.00 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.00 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AVO.L
What is AVO.L's current stock price?
Advanced Oncotherapy plc (AVO.L) is currently trading at $1.75 per share. The stock has moved -9.09% today.
What is the analyst price target for AVO.L?
No analyst price targets are currently available for this stock.
What sector is Advanced Oncotherapy plc in?
Advanced Oncotherapy plc operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the LSE exchange.
What is AVO.L's market cap?
Advanced Oncotherapy plc has a market capitalization of $0.01 billion, making it a small-cap company.
Does AVO.L pay dividends?
No, Advanced Oncotherapy plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBELL.L
Belluscura plc
$0.75
Mkt Cap: $0.3B
BVX.L
BiVictriX Therapeutics Plc
$10.00
Mkt Cap: $0.8B
CEL.L
Celadon Pharmaceuticals Plc
$13.40
Mkt Cap: $0.9B
CLAI.L
Cel AI PLC
$0.13
Mkt Cap: $0.1B
INHC.L
Induction Healthcare Group PLC
$9.75
Mkt Cap: $0.9B
KNB.L
Kanabo Group Plc
$0.23
Mkt Cap: $0.1B
MXC.L
MGC Pharmaceuticals Limited
$21.20
Mkt Cap: $0.9B
NSCI.L
NetScientific plc
$53.12
Mkt Cap: $1.3B
RGT.L
Argent BioPharma Limited
$6.00
Mkt Cap: $0.4B
SNG.L
Synairgen plc
$0.95
Mkt Cap: $1.2B
Explore stocks similar to AVO.L for comparison